Groundbreaking research reveals distinct biological signatures differentiating Type 1 Diabetes-associated HFpEF from obesity-related HFpEF
Discover how prebiotics and gut microbiome can revolutionize diabetes management through improved blood sugar control and insulin sensitivity.
Explore how Lactobacillus bacteria can reduce diabetes risk by modulating gut microbiome and inhibiting key digestive enzymes in high-fat diet-induced diabetic mice.
Explore how the MILES study is uncovering the connection between gut microbiome and type 2 diabetes through longitudinal research on insulin homeostasis.
Discover how gut microbiota influences medication effectiveness, particularly clopidogrel in type 2 diabetic patients.
Exploring the oral fungal microbiome in diabetic patients from Benghazi, Libya, and its implications for diabetes management and oral health.